Literature DB >> 6136722

Sclerosing peritonitis after CAPD.

J A Bradley, D N Hamilton, D L McWhinnie, J D Briggs, B J Junor.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6136722     DOI： 10.1016/s0140-6736(83)90600-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Classification of encapsulating peritoneal sclerosis is important, but must encapsulate the entire spectrum of the disease.

Authors:  Christopher J E Watson; Andrew J Butler; J Andrew Bradley
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

2.  Adipose tissue behavior is distinctly regulated by neighboring cells and fluid flow stress: a possible role of adipose tissue in peritoneal fibrosis.

Authors:  Shigehisa Aoki; Kazuma Udo; Hiroyuki Morimoto; Satoshi Ikeda; Toshiaki Takezawa; Kazuyoshi Uchihashi; Aki Nishijima-Matsunobu; Mitsuru Noguchi; Hajime Sugihara; Shuji Toda
Journal:  J Artif Organs       Date:  2013-03-24       Impact factor: 1.731

3.  Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease.

Authors:  G P Krestin; G Kacl; M Hauser; G Keusch; H R Burger; R Hoffmann
Journal:  Abdom Imaging       Date:  1995 Sep-Oct

4.  Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.

Authors:  Zhenghong Li; Lu Zhang; Weiming He; Changle Zhu; Jinsong Yang; Meixiao Sheng
Journal:  Int J Mol Sci       Date:  2014-07-22       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.